| De Spiegeleer, Bart |
ORCID
|
| A1 Publications (5) [show] |
 Cooreman, K.; De Spiegeleer, B.; Van Poucke, C.; Vanavermaete, D.; Delbare, D.; Wynendaele, E.; De Witte, B. (2023). Emerging pharmaceutical therapies of Ascidian-derived natural products and derivatives. Environ. Toxicol. Pharmacol. 102: 104254. https://dx.doi.org/10.1016/j.etap.2023.104254, more- Janssens, Y.; Wynendaele, E.; Vanden Berghe, W.; De Spiegeleer, B. (2019). Peptides as epigenetic modulators: therapeutic implications. Clinical Epigenetics 11: 101. https://dx.doi.org/10.1186/s13148-019-0700-7, more
- Gevaert, B.; Veryser, L.; Verbeke, F.; Wynendaele, E.; De Spiegeleer, B. (2016). Fish hydrolysates: a regulatory perspective of bioactive peptides. Protein and Peptide Letters 23(12): 1052-1060. https://dx.doi.org/10.2174/0929866523666161102122637, more
- Schaeck, M.; De Spiegelaere, W.; De Craene, J.; Van Den Broeck, W.; De Spiegeleer, B.; Burvenich, C.; Haesebrouck, F.; Decostere, A. (2016). Laser capture microdissection of intestinal tissue from sea bass larvae using an optimized RNA integrity assay and validated reference genes. NPG Scientific Reports 6: 21092. https://dx.doi.org/10.1038/srep21092, more
- Stalmans, S.; Willems, M.; Adriaens, E.; Remon, J.-P.; D'Hondt, M.; De Spiegeleer, B. (2014). Flatworm models in pharmacological research: the importance of compound stability testing. Regul. Toxicol. Pharmacol. 70(1): 149-154. https://dx.doi.org/10.1016/j.yrtph.2014.06.026, more
|
|
